Stock NWRN NEWRON PHARMACEUTICALS S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Newron Pharmaceuticals S.p.A.

Equities

NWRN

IT0004147952

Delayed Swiss Exchange
Other stock markets
 11:30:02 2024-05-17 am EDT 		5-day change 1st Jan Change
10.6 CHF +1.53% Intraday chart for Newron Pharmaceuticals S.p.A. +8.38% +114.14%
Apr. 30 Newron Pharmaceuticals S.p.A. Announces Positive Top-line Results From Potentially Pivotal Phase II/III Study 008A With Evenamide in Schizophrenia Patients CI
Apr. 17 Newron Pharmaceuticals Appoints Margarita Chavez as Independent Board Member CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Biopharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NEWRON PHARMACEUTICALS S.P.A. Stock Newron Pharmaceuticals S.p.A.
 218M
CSL LIMITED Stock CSL Limited
 90.45B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
 41.45B
BIOGEN INC. Stock Biogen Inc.
 33.57B
UCB Stock UCB
 25.73B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
 14.73B
  1. Stock Market
  2. Equities
  3. NWRN Stock
  4. Charts Newron Pharmaceuticals S.p.A.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW